-
CARD study: cabazitaxel benefit independent of the previous NHT-Dox sequence. Even more subgroup analysis indicative that the caba benefit may apply to pts that received initial NHT for more than 12 months.
#ESMOdaily@PGrivasMDPhD@OneoYoc@PTsantoulis@AKyriazoglou@MKapareloupic.twitter.com/j8Nsc1drbD
-
#ESMO19: Immunotherapy fails to improve PFS and OS in relapsed mesothelioma#ESMOdaily#oncoalert#lcmeshttp://ow.ly/u1kc50wxYea -
Day 2 at
#ESMO19 means the 2nd edition of the#ESMOdaily Reporter is now available. Missed your copy? Why not not check out the online version: http://dailyreporter.esmo.org/ pic.twitter.com/mypkpuGGzH
-
@breakingnewsie calling human beings, mothers, fathers, siblings, sons, daughters we love dearly many of who did not survive "Test Subjects" is highly offensive even if you're just re-hashing other reports#wordsmatter#ESMOdaily#ESMO2019#Melanoma#MelSM#CheckmateO67pic.twitter.com/uuvsbZF8aT
Prikaži ovu nit -
ESMO19 Insights >>> Published by Roberto Alfaro in Twitter: RT
@myESMO:#ESMO19: Fake news in#cancer: how#oncologists can address the issue#ESMOdaily… http://dlvr.it/RFWF2t#ESMO19#followthepatient#LucidQuest#strategy#cancer#insights#immunotherapy#oncologypic.twitter.com/3kdRA3sZNH
-
ESMO19 Insights >>> Published by HCC CONNECT in Twitter: RT
@myESMO:#ESMO19:#Precisionmedicine bursts onto the biliary tract cancer scene#ESMOdaily#oncoalert… http://dlvr.it/RFTbZH#ESMO19#followthepatient#LucidQuest#oncology#immunotherapy#strategy#cancer#insightspic.twitter.com/ToJ8FOxoED
-
#ESMO19: INVICTUS trial - positive results for patients with GIST#ESMOdaily#oncoalerthttp://ow.ly/hYu350wxYrP -
#DrugPricing is a continum debate on the accessibility and affordability of innovative medicines. B Jönsson discusses what is fair pricing in#oncology
http://ow.ly/DsNd50xcoOf #ESMOdaily pic.twitter.com/kXeaJVLJu6
-
From
#ESMO19: Are we reaching a turning point in metastatic#prostatecancer?#ESMOdaily#PCSMhttp://ow.ly/qRca50xbWRu -
#ESMO19: Fake news in#cancer: how#oncologists can address the issue#ESMOdaily http://ow.ly/DFEj50wBAE9 -
The latest EMJ Daily Newsletter! http://news.emjreviews.com/?edition_id=8a4960c0-e41d-11e9-bcba-0cc47a0d1605 … Thanks to
@EMJOncology#esmo19#esmodaily -
And the other half are still dying let's not forget them
#lotstodo#ESMOdaily#ESMO2019https://www.bbc.com/news/amp/health-49853878?__twitter_impression=true … -
It's the first day of
#esmo2019 in#Barcelona today and our team of medical writers and designers are on site to deliver each edition of the Daily Reporter. Have you picked up your copy of today's edition yet? We'd love to know your thoughts...#medcomms#oncology#ESMOdaily pic.twitter.com/0mBjq7EWJU
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.